Evaluation of long-term results and recurrent factors after operative and nonoperative treatment for hepatolithiasis

被引:176
作者
Cheon, Young Koog
Cho, Young Deok
Moon, Jong Ho
Lee, Joon Seong
Shim, Chan Sup
机构
[1] Soon Chun Hyang Univ, Coll Med, Inst Digest Res, Seoul, South Korea
[2] Soon Chun Hyang Univ, Coll Med, Ctr Digest Dis, Seoul, South Korea
关键词
TRANS-HEPATIC CHOLANGIOSCOPY; INTRAHEPATIC STONES; BILIARY STRICTURES; CHOLANGIOCARCINOMA; LITHOTRIPSY; MANAGEMENT; LITHOTOMY; RESECTION; REMOVAL;
D O I
10.1016/j.surg.2009.04.009
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. Hepatolithiasis is a common disease in East Asia. Operative and nonoperative procedures for the management of hepatolithiasis have been discussed, but long term follow-up results of such treatments are only reported rarely. We evaluated the long-term results of of operative and nonoperative treatments and examined risk factors for the recurrence of stones or cholangitis. Methods. We conducted a retrospective study of case records of patients with hepalolithiasis who underwent treatment by operative therapy or nonoperative percutaneous transhepatic cholangioscopy (PTCS), or peroral cholangioscopy. Of 311 patients with hepatolithiasis, 236 underwent follow-up after operative (n = 90), PTCS (n = 97), or peroral cholangioscopy (n = 49) treatment. Results. Complete stone clearance was achieved in 83.3% of hepatectomy, 63.9% of PTCSL, and 57.1% of peroral cholangioscopy patients. After a median follow-up period of 8.0 years (up to 37 years), we observed stone recurrence in 30.9% (73/236) of patients, secondary biliary cirrhosis in 8.5% (191224), late development of cholangiocarcinoma in 4.8% (11/227), and a mortality rate of 8.1% (19/236). Stricture, stones in both lobes, and nonoperative treatments were significant risk factors for incomplete stone clearance on multivariate analysis. In addition, recurrent stones and/or cholangitis were associated with nonoperative therapy (hazard ratio [HR], 2.01; 95% confidence interval [CI], 1.10-3.65), biliary cirrhosis (HR, 2.22; 95 % CI, 1.24-3.98), residual stones (HA 1.98; 95 % CI, 1.24-3.17), and stricture (HR, 1.86; 95 % CI, 1.01-3.43). Conclusion. In this long-term follow-up study, nonoperative therapy, biliary cirrhosis, residual stones, and biliary stricture were associated with recurrent stones and/or cholangitis after treatment. (Surgery 2009;146;843-53.)
引用
收藏
页码:843 / 853
页数:11
相关论文
共 22 条
[11]   PERCUTANEOUS TRANS-HEPATIC CHOLANGIOSCOPIC LITHOTOMY FOR HEPATOLITHIASIS - LONG-TERM RESULTS [J].
JAN, YY ;
CHEN, MF .
GASTROINTESTINAL ENDOSCOPY, 1995, 42 (01) :1-5
[12]   Surgical treatment of hepatolithiasis: Long-term results [J].
Jan, YY ;
Chen, MF ;
Wang, CS ;
Jeng, LB ;
Hwang, TL ;
Chen, SC .
SURGERY, 1996, 120 (03) :509-514
[13]   LIMITATIONS OF PERCUTANEOUS TRANS-HEPATIC CHOLANGIOSCOPY IN THE REMOVAL OF COMPLICATED BILIARY CALCULI [J].
JENG, KS ;
CHIANG, HJ ;
SHIH, SC .
WORLD JOURNAL OF SURGERY, 1989, 13 (05) :603-610
[14]   BILE-DUCT STENTS IN THE MANAGEMENT OF HEPATOLITHIASIS WITH LONG-SEGMENT INTRAHEPATIC BILIARY STRICTURES [J].
JENG, KS ;
YANG, FS ;
CHIANG, HJ ;
OHTA, I .
BRITISH JOURNAL OF SURGERY, 1992, 79 (07) :663-666
[15]   Natural progression of untreated hepatolithiasis that shows no clinical signs at its initial presentation [J].
Kusano, T ;
Isa, T ;
Ohtsubo, M ;
Yasaka, T ;
Furukawa, M .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2001, 33 (02) :114-117
[16]   Percutaneous transhepatic cholangioscopic treatment for hepatolithiasis: an evaluation of long-term results and risk factors for recurrence [J].
Lee, SK ;
Seo, DW ;
Myung, SJ ;
Park, ET ;
Lim, BC ;
Kim, HJ ;
Yoo, KS ;
Park, HJ ;
Joo, YH ;
Kim, MH ;
Min, YI .
GASTROINTESTINAL ENDOSCOPY, 2001, 53 (03) :318-323
[17]  
NIMURA Y, 1981, Stomach and Intestine (Tokyo), V16, P681
[18]   Peroral cholangioscopic treatment of hepatolithiasis: long-term results [J].
Okugawa, T ;
Tsuyuguchi, T ;
Sudhamshu, KC ;
Ando, T ;
Ishihara, T ;
Yamaguchi, T ;
Yugi, H ;
Saisho, H .
GASTROINTESTINAL ENDOSCOPY, 2002, 56 (03) :366-371
[19]   Ductal dilatation and stenting for residual hepatolithiasis: a promising treatment strategy [J].
Sheen-Chen, SM ;
Cheng, YF ;
Chen, FC ;
Chou, FF ;
Lee, TY .
GUT, 1998, 42 (05) :708-710
[20]   Hepatolithiasis associated with cholangiocarcinoma [J].
Su, CH ;
Shyr, YM ;
Lui, WY ;
Peng, FK .
BRITISH JOURNAL OF SURGERY, 1997, 84 (07) :969-973